sults in progressive c e n t r a l nervous system(CNS) bleeding which subsides by day 10-12 and i s followed by the development of hydrocephalus. The use of F'b 210 permitted a correlation between the dose of F'D, t i s s u e Pb levels,morbidity,and mortality. Increasing the Pb dose resulted i n increasing CNS damage, mortali t y , & increasing concentrations of t o t a l body,blood and brain Pb. Injection of Pb a f t e r day 11 was accompanied by a marked decrease i n morbidity and mortality. This was associated with reduced brain Pb concentrations, but no decrease in blood Pb 1evels.This indicates the developrent of a blood-brain b a r r i e r t o Pb a t t h i s period in developrent and corresponds t o the formation of specialized endothelial junctions i n the CNS. Administration of Ca Edta a t i n t e r v a l s a f t e r Pb i n j e c t i o n on day h enabled delineation of the minimum period required f o r the occurrence of Pb toxicity. Edta given 2 minutes a f t e r F'D resulted i n complete-protection a i n s t Pb induced CNS damage a d \ mortality. A t i n t e r v a l s up to? hours there was a substantial diminution i n morbidity and mortality. A t longer i n t e r v a l s lit- I n infants BMRs a r e lower in prenatal than i n postnatal ons e t growth f a i l u r e . The significance of t h i s was investigated i n r a t s with similar types of growth f a i l u r e by r e l a t i n g t h e i r BHR t o body weight (BWt), combined organ (0: l i v e r , kidney.
heart, and brain) weight (OWt). DNA (ODNA), and protein (OPr). Mature r a t s were fed a 6% protein d i e t 1 month prior t o and during mating, gestation, and lactation. Offsprings were fed 27% protein a t weaning (A). Offsprings of normal r a t s were fed lov protein from weaning t o 10 weeks and high protein up t o weight recovery (B). The i n s u l t caused permanent stunting i n group A r a t s ; 314 of group B r a t s had normal veights by 24
weeks. Sleeping BMRB were measured i n 4 r a t s of each group before s a c r i f i c i n g . a t veaning, 10. 16, and >16 weeks, and i n litter-mates weekly up t o maturity. The r e l a t i o n of t h e BMR with BWt, OWt, and OPr was curvi-linear; t h a t with ODNA was l i n e a r . These r e l a t i o n s were similar f o r normal controls. The IMR per BWt. OWt, and OPr decreased with age a s c e l l s i z e increased. The i n s u l t s affected ODNA and OPr of l i v e r , kidney. and heart i n both groups but not of brain. Recovery paralleled weight recovery. Recovery of c e l l s i z e occurred f i r s t . The data show t h a t t h e BHR r e f l e c t s c e l l number r a t h e r than c e l l mass. Comparison of t h e BMRs suggests t h a t t h e i n s u l t of group A r a t s was not comparable t o t h a t which caused dwarfing i n i n f a n t s with growth f a i l u r e of prenatal onset.
o n v e r s i o n o f L -g l u t a m a t e (L-glu) t o y-aminob u t y r a t e (GABA) i n mammalian b r a i n 6 k i d n e y i s catal y z e d by p y r i d o x a l -p h o s p h a t e (PLE')-dependent GAD.

GABA i s an i m p o r t a n t n e u r o -i n h~b i t o r i n CNS, b u t a n o t h e r r o l e m u s t e x i s t f o r GABA m e t a b o l i s m i n k i dn e y c o r t e x . W e a s s a y e d GAD by an i s o t o p i c method
( L a n c a s t e r e t a l , BBA =:229,1973) a t n o r m a l t i s s u e L-glu c o n c . (4-8mM) tPLE' (0.24mM) i n f r o z e n p o s tmortem human k i d n e y o b t a i n e d b e t w e e n l5wk g e s t a t i o n a n d 10yr.GAD i s stable i n t i s s u e s o r homogenates s t o r e d a t -20°C; P L P -s a t u r a t e d r e n a l GAD a c t i v i t y i s low ( < 0 . 5 n m o l e s CO2 formed/mg w e t w t -h ) b e f o r e 4Owks gestation, t h e n rises a t t e r m a n d p l a t e a u s i n t h e i n f a n t 6 c h i l d a t 5 -l o x f e t a l level. Kidney GABA c o n c . p a r a l l e l s GAD a c t i v i t y . Endogenous GAD a c t iv i t y i s o f t e n inappropriately low f o r a g e , b u t c a n b e s t i m u l a t e d by PLP i n v i t r o , I n d i c a t i n g , u n d e rs a t u r a t i o n by co-enzyme i n vivo; o n c e bound i n vivo, PLP i s n o t e a s i l y removed f r o m GAD i n v i t r o . Augment a t i o n o f r e n a l GAD a c t i v i t y a t t e r m p a r a l l e l s t h e n e e d f o r human k l d n e y t o e x t r a c t g l u t a m i n e f r o m p l a s m a t o s u p p o r t r e n a l ammoniagenesis. The GABA pathway p e r m i t s d i s p o s a l o f t h e r e s i d u a l g l u t a m a t e c a r b o n c h a i n a s a n o n -t i t r a t a b l e a c i d . The frequent episodes of peribronchial pneumonia seen i n patients with c y s t i c f i b r o s i s require a n t i b i o t i c administration often with anti-staphylococcal agents. Until now the data upon which t o base dosage regimens have not been available. Serum dicloxacillin concentrations and urinary excretion r a t e s were measured i n 10 patients ranging i n age from 9 t o 22 years and i n 5 normal adult subjects a t various times a f t e r o r a l admini s t r a t i o n of a single dose (6.25 mg/kg) of a n t i b i o t i c suspension i n order t o investigate absorption and disposition kineti c s . The disease did not appear t o cause impaired absorption of the a n t i b i o t i c since the t o t a l urinary recovery of the drug i n the patients usually exceeded that of normal subjects. However, the peak plasma levels and areas under the concentration versus time curves of dicloxacillin were much lower and more variable i n the patients than i n the normal subjects. Less ant i b i o t i c i s therefore available for therapeutic e f f e c t . This was the result of unusually high renal clearances of diclox a c i l l i n (3x normal). I t was s i g n i f i c a n t that the dicloxacillin :creatinine clearance r a t i o s (1.55 versus 0.87, respectively) were larger i n the patients than i n normal subjects. Because of t h i s rapid renal e x~r e t i o n~t r e a t m e n t of cystic f i b r o s i s patients with dicloxacillin warrants use of increased doses. Measurements of the serum concentration of the a n t i b i o t i c may be needed t o assure adequacy of therapy.
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